10x Genomics strikes back in Bio-Rad saga with USITC ban
13-02-2020
Michael Vi / Shutterstock.com
The US Court of Appeals for the Federal Circuit has upheld a decision from the US International Trade Commission (ITC) that found 10X Genomics infringed on two Bio-Rad Laboratories gene sequencing patents.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
Start a subscription today to access the LSIPR website
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at achoudhury@newtonmedia.co.uk
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
Patents, Bio-Rad, 10X Genomics, ITC